A detailed history of Deutsche Bank Ag\ transactions in Biote Corp. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 43 shares of BTMD stock, worth $108. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43
Previous 31,441 99.86%
Holding current value
$108
Previous $126,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$2.82 - $4.55 $88,542 - $142,860
-31,398 Reduced 99.86%
43 $0
Q4 2024

Feb 14, 2025

BUY
$5.04 - $6.93 $155,347 - $213,603
30,823 Added 4987.54%
31,441 $196,000
Q3 2024

Jun 26, 2025

SELL
$5.33 - $8.36 $164,286 - $257,680
-30,823 Reduced 98.03%
618 $3,000
Q2 2024

Jun 12, 2025

SELL
$5.44 - $7.47 $167,677 - $230,247
-30,823 Reduced 98.03%
618 $4,000
Q2 2024

Aug 14, 2024

BUY
$5.44 - $7.47 $3,361 - $4,616
618 New
618 $4,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $19.1M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.